
About Us We are a leading gastrointestinal health company delivering minimally invasive diagnostics to transform access to esophageal care. Our EndoSign test combines a simple, swallowable device with cutting-edge laboratory biomarkers and analytics to detect esophageal cancer and its precursor, Barrett’s esophagus. Operating across the US and UK life-science hub, with hybrid, remote and onsite teams, we are expanding our pipeline to address new high-impact targets across gastroenterology and re
About Us We are a leading gastrointestinal health company delivering minimally invasive diagnostics to transform access to esophageal care. Our EndoSign test combines a simple, swallowable device with cutting-edge laboratory biomarkers and analytics to detect esophageal cancer and its precursor, Barrett’s esophagus. Operating across the US and UK life-science hub, with hybrid, remote and onsite teams, we are expanding our pipeline to address new high-impact targets across gastroenterology and re
About Us We are a leading gastrointestinal health company delivering minimally invasive diagnostics to transform access to esophageal care. Our EndoSign test combines a simple, swallowable device with cutting-edge laboratory biomarkers and analytics to detect esophageal cancer and its precursor, Barrett’s esophagus. Operating across the US and UK life-science hub, with hybrid, remote and onsite teams, we are expanding our pipeline to address new high-impact targets across gastroenterology and re
About Us We are a leading gastrointestinal health company delivering minimally invasive diagnostics to transform access to esophageal care. Our EndoSign test combines a simple, swallowable device with cutting-edge laboratory biomarkers and analytics to detect esophageal cancer and its precursor, Barrett’s esophagus. Operating across the US and UK life-science hub, with hybrid, remote and onsite teams, we are expanding our pipeline to address new high-impact targets across gastroenterology and re